Citations

Mayo Clinic

Showing 10 of 108599 citations.

Differential Accumulation of Secreted AβPP Metabolites in Ocular Fluids1
Prakasam, A. , Muthuswamy, Anusuya, Ablonczy, Zsolt, Fauq, Abdul H. , Rao, K. S. , Pappolla, Miguel A. , Sambamurti, Kumar , Fauq, Abdul, Greig, Nigel H.

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 20 | Issue: 4 | Pages: 1243-1253

10.3233/jad-2010-100210 | PMID 20413851 Get It

Amyloid-β (Aβ) accumulates in several types of retinal degeneration and in Alzheimer’s disease (AD), but its source has been unclear. We detected the neuronal 695 amino acid form of amyloid-β protein precursor (AβPP) in the normal retina and AβPP751 in the retinal pigment epithelium (RPE) and anterior eye tissues. Similar to the brain, a- and β-secretases cleaved AβPP to soluble derivatives (sAβPP) a or β and membrane-bound C-terminal fragments a or β in the retina and RPE. Levels of sAβPP were particularly high in the vitreous and low in aqueous humor revealing a molecular barrier for AβPP. In contrast, Aβ40 and Aβ42 levels were only 50% lower in the aqueous than the vitreous humor, indicating relatively barrier-free movement of Aβ. These studies demonstrated a relatively high yield of AβPP and Aβ in the ocular fluids, which may serve as a trackable marker for AD. In addition, failure of free clearance from the eye may trigger retina degeneration in a manner similar to Aβ-related neurodegeneration in AD.
Vascular Risk Factors: Imaging and Neuropathologic Correlates
Roberts, Rosebud O., Knopman, David S.

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 20 | Issue: 3 | Pages: 699-709

10.3233/jad-2010-091555 | PMID 20182020 Get It

Evidence-Based Medicine: Application in Alzheimer's Disease Research
Murad, M. Hassan , Montori, Víctor M. , Murad, M Hassan , Montori, Victor M

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 20 | Issue: 3 | Pages: 935-942

10.3233/jad-2010-1419 | PMID 20182041 Get It

Changes in the Expression of Genes Associated with Intraneuronal Amyloid-β and Tau in Alzheimer's Disease
Fujimura, Robert K., Reiner, Teresita, Ma, Fangchao , Phillips, Virginia , Pozas, Alicia de las, Dickson, Dennis W. , Roos, Bernard A., Howard, Guy A., Perez‐Stable, Carlos , Dickson, Dennis W

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 19 | Issue: 1 | Pages: 97-109

10.3233/jad-2010-1216 | PMID 20061629 Get It

Developing a Research Agenda for Integrating Palliative Care into Critical Care and Pulmonary Practice To Improve Patient and Family Outcomes
Reinke, Lynn F. , Cox, Christopher E. , Kross, Erin K. , Benzo, Roberto P. , Curtis, J. Randall , Aslakson, Rebecca A.

Journal of Palliative Medicine | April 5, 2017 | Volume: 20 | Issue: 4 | Pages: 329-343

10.1089/jpm.2016.0567 | PMID 28379812 Get It

Temporal Relationship between Depressive Symptoms and Cognitive Impairment: The Italian Longitudinal Study on Aging
Panza, Francesco , D’Introno, Alessia , Colacicco, Anna M., Capurso, Cristiano , Parigi, Angelo Del, Caselli, Richard J. , Frisardi, Vincenza , Scapicchio, Pierluigi, Chiloiro, Roberta, Scafato, Emanuele , Gandin, Claudia , Vendemiale, Gianluigi, Capurso, Antonio, Solfrizzi, Vincenzo , Scapicchio, Pier Luigi, Vendemiale, Gianluigi

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 17 | Issue: 4 | Pages: 899-911

10.3233/jad-2009-1111 | PMID 19542612 Get It

Meeting report of the 2016 bone marrow adiposity meeting
Eerden, Bram C. J. van der , Wijnen, André J. van , van Wijnen, Andre, van Wijnen, Andre J , van der Eerden, Bram C J

Adipocyte | April 5, 2017 | Volume: 6 | Issue: 4 | Pages: 304-313

10.1080/21623945.2017.1313374 | PMID 28410005 Get It

Apparent Behavioral Benefits of Tau Overexpression in P301L Tau Transgenic Mice
Morgan, Dave, Munireddy, Sanjay, Alamed, Jennifer, DeLeon, Jason, Diamond, David M. , Hutton, Michael , Lewis, Jada , Gordon, Marcia N. , Bickford, Paula C. , McGowan, Eileen

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 15 | Issue: 4 | Pages: 605-614

10.3233/jad-2008-15407 | PMID 19096159 Get It

Immunoresponsive Autonomic Neuropathy in Sjögren Syndrome—Case Series and Literature Review
Goodman, Brent P.

American Journal of Therapeutics | April 5, 2017 | Volume: 26 | Issue: 1 | Pages: e66-e71

10.1097/mjt.0000000000000583 | PMID 28379880 Get It

Background: Sjögren syndrome (SS) is one of the most common autoimmune disorders that classically affects exocrine glands, resulting in keratoconjunctivitis sicca and xerostomia, and frequently is associated with other systemic symptoms. SS appears to have a particular predilection for involving the autonomic nervous system. Study Question: Does immunotherapy improve signs and symptoms of autonomic nervous system impairment in SS? Study Design: This is a retrospective review of patients seen in the autonomic clinic at our institution who underwent an evaluation for a suspected autonomic disorder that ultimately was attributed to SS. SS patients who were treated with immunotherapy and completed autonomic testing before and after treatment were included in this review. Results: A total of 4 patients were identified who were treated for SS-related autonomic dysfunction with immunotherapy and underwent repeat autonomic testing after treatment. Marked clinical and functional improvement was seen after treatment with intravenous immunoglobulin in all patients and adjunctive rituximab therapy in 1 patient. The clinical improvement with immunotherapy in these patients correlated with markedly improved findings on autonomic testing in all. Measures and Outcomes: Clinical symptoms and results of autonomic testing prior to and following immunotherapy were assessed. Conclusions: Autonomic signs and symptoms in SS are potentially immunoresponsive, but immunotherapy in these patients may require repeated, ongoing, or adjunctive therapy for optimal and sustained improvement.
Extent of diagnostic agreement among medical referrals
Such, Monica Van , Lohr, Robert H., Beckman, Thomas J. , Naessens, James M. , Van Such, Monica , Lohr, Robert, Beckman, Thomas

Journal of Evaluation in Clinical Practice | April 5, 2017 | Volume: 23 | Issue: 4 | Pages: 870-874

10.1111/jep.12747 | PMID 28374457 Get It

AbstractRationale, aims and objectivesDiagnostic uncertainty is often encountered in a medical practice. Patients with ambiguous, uncertain, and undiagnosed problems are frequently referred for second opinions. Comparing referral diagnoses to final diagnoses provides an opportunity to determine how frequently final diagnoses vary and changes the direction of medical care.MethodsA retrospective study was done at a single academic medical center using a sample of 286 patients referred by physician assistants, nurse practitioners, and physicians from primary care practices from January 1, 2009 to December 31, 2010. Patients' referral and final diagnoses were compared and classified into 1 of 3 categories: referral diagnosis and final diagnosis the same, referral diagnosis better defined/refined, and referral diagnosis distinctly different from final diagnosis. Episode costs for the respective categories were calculated for the referral visit and services that occurred at our facility within the first 30 days.ResultsIn 12% (36/286) of cases, referral diagnoses were the same as final diagnoses. Final diagnoses were better defined/refined in 66% (188/286) of cases; but in 21% of cases (62/286), final diagnoses were distinctly different than referral diagnoses. Total costs for cases in category 3 (different final diagnoses) were significantly higher than costs for cases in category 1 (P = .0001) and category 2 (P = <.0001).ConclusionReferrals to advanced specialty care for undifferentiated problems are an essential component of patient care. Without adequate resources to handle undifferentiated diagnoses, a potential unintended consequence is misdiagnoses resulting in treatment delays and complications leading to more costly treatments.